Recursion to report Q2 2026 financial results and host earnings call on August 5

Recursion Pharmaceuticals announced it will release its second quarter 2026 financial results on August 5, 2026, before the market opens. The company will also hold a public earnings call at 8:00 AM ET the same day, streamed live on its social media channels. Recursion is a clinical-stage TechBio company using AI-driven drug discovery to develop medicines in oncology, rare diseases, and other fields. This update is important for investors to assess the company's progress and future outlook in its innovative drug development pipeline.